Home » Topics » Regulatory » EMA

EMA
RSS

EMA's CHMP supports approval of adalimumab biosimilar Imraldi

June 26, 2017

EMA gives positive opinion to Gilead Sciences' Vosevi

June 26, 2017

EMA validates Veyvondi MAA

June 22, 2017

EMA accepts Novartis' MAA filing for erenumab

June 22, 2017

Tarix Orphan's TXA-127 granted orphan drug status in E.U. for epidermolysis bullosa

June 13, 2017

Hemophilia A gene therapy from Sangamo and Pfizer receives E.U. orphan drug designation

June 7, 2017

EMA's COMP recommends orphan medicinal product designation for Catalyst Biosciences' CB-2679d

June 1, 2017

Dasiglucagon receives positive opinion for designation as orphan medicinal product

May 30, 2017

EMA grants PRIME designation for asunercept as treatment of glioblastoma

May 30, 2017

Myrcludex B granted EMA PRIME eligibility

May 26, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026